Cutibacterium acnes proteins (C. acnes proteins)

Cutibacterium acnes proteins encompass the diverse array of structural, enzymatic, and virulence-related proteins produced by the Gram-positive anaerobic bacterium C. acnes, a primary commensal of human skin. While part of the normal flora, these proteins play a critical role in the pathogenesis of acne vulgaris by promoting follicular hyperkeratinization and inducing potent inflammatory responses through the activation of Toll-like receptors (TLR2 and TLR4) on keratinocytes and macrophages (Source: StatPearls, PMID: 29494039). Key proteins include lipases, which degrade sebum triglycerides into irritating free fatty acids, and CAMP factors, which exert hemolytic and cytotoxic effects on host cells (Source: PubMed, PMID: 30305570). Therapeutic strategies targeting these proteins primarily involve antibiotics like clindamycin and tetracyclines, which inhibit the bacterial ribosome to halt protein synthesis, or oxidizing agents like benzoyl peroxide that non-specifically denature bacterial proteins (Source: Mayo Clinic). Recent drug development has shifted toward more specific targeting of C. acnes virulence factors and biofilm-associated proteins to mitigate the rising challenge of antibiotic resistance (Source: Journal of Investigative Dermatology, PMID: 31202715). Understanding the C. acnes proteome is essential for developing narrow-spectrum therapies that preserve the skin's beneficial microbial ecology while suppressing pathogenic activity.

Other names

Propionibacterium acnes proteinsC. acnes proteomeAcne bacillus proteins

Inhibition of bacterial protein synthesis by binding to the 30S or 50S ribosomal subunits; oxidative destruction of bacterial proteins; inhibition of extracellular enzymes such as lipases and hyaluronidases.